Synthesis of Pluronic® F127-poly (methyl vinyl ether-alt-maleic acid) copolymer and production of its micelles for doxorubicin delivery in breast cancer

Chemical Engineering Journal

Volumn 240, Issue , 2014, Pages 133-146

  Varshosaz, J ^a   Hassanzadeh, F ^a   Sadeghi aliabadi, H ^a   Larian, Z ^a   Rostami, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Copolymer; Doxorubicin; Micelle; Pluronic F127; Poly (methyl vinyl ether alt maleic acid)

Indexed keywords

BREAST CANCER; CARRIER FOR DELIVERIES; CRITICAL MICELLE CONCENTRATION (CMC); DICYCLOHEXYLCARBODIIMIDE; DOXORUBICIN; DRUG-LOADING EFFICIENCY; PLURONICS; POLY (METHYL VINYL ETHER-ALT-MALEIC ACID);

COPOLYMERS; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DISEASES; DRUG PRODUCTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; ZETA POTENTIAL;

MICELLES;

EID: 84890823140     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2013.11.086     Document Type: Article

References (64)

1. Greenwald P. Clinical trials in cancer prevention: current results and perspectives for the future. J. Nutr. 2004, 134:3507S-3512S.
2. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 2000, 50:7-33.
3. Pettersson F., Couture M.C., Hanna N., Miller W.H. Enhanced retinoid-induced apoptosis of MD MB 231 breast cancer cells by PKC inhibitors involves activation of ERK. Oncogene 2004, 23(42):7053-7066.
4. Jones K.L. Breast cancer. Koda-Kimble and Young's Applied Therapeutics, the Clinical Use of Drugs 2012, 2129-2199. Lippincott Williams & Wilkins, New York. 10th ed. B.K. Alldredge, R.L. Corelli, M.E. Ernst (Eds.).
5. Marco A.D., Gaetani M., Scarpinato B. Adriamycin (NSC-123, 127): a new antibiotic with antitumor activity. Cancer Chemother. 1969, 53:33-37.
6. Ganz W.I., Sridhar K.S., Ganz S.S., Gonzalez R., Chakko S., Serafini A. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 1996, 53(6):461-470.
7. Nip J., Strom D.K., Fee B.F., Zambetti G., Cleveland J.L., Hiebert S.W. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell Biol. 1997, 17(3):1049-1056.
8. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumor tropic accumulation of proteins and antitumor agent SMANCS. Cancer Res. 1986, 46:6387-6392.
9. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Rel. 2001, 73:137-172.
10. Rapoport N. Stabilization and activation of Pluronic® micelles tumor-targeted drug delivery. Coll. Surf. B: Biointerf. 1999, 16:93-111.
11. Rapoport N.Y., Herron J.N., Pitt W.G., Pitina L. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake. J. Control. Rel. 1999, 58:153-162.
12. Adams M.L., Lavasanifar A., Kwon G.S. Amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 2003, 92:1343-1355.
13. Garinot M., Fievez V., Pourcelle V., Stoffelbach F., Rieux A., Plapied L. PEGylated PLGA-based nanoparticle targeting M cells for oral vaccination. J. Control. Rel. 2007, 120:195-204.
14. Batrakova E.V., Dorodnych T.Y., Klinskii E.Y., Kliushnenkova E.N., Shemchukova O.B., Goncharova O.N., Arjakov S.A., Alakhov V.Y., Kabanov A.V. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br. J. Cancer 1996, 74:1545-1552.
15. Kabanov A.V., Batrakova E.V., Alakhov V.Yu. Pluronic® block copolymers for overcoming drug resistance in cancer. Adv. Drug. Deliv. Rev. 2002, 54:759-779.
16. Tian Y., Bromberg L., Lin S.N., Alen Hatton T., Tam Cam C. Complexation and release of doxorubicin from it complexes with Pluronic® P85-poly(acrylic acid) block copolymers. J. Control. Rel. 2007, 121:137-145.
17. Melik-Nubarov N.S., Kozlov M.Yu. Evaluation of partition coefficients of low molecules weight solutes between water and micelles of block copolymer of ethylene oxide based on dialysis kinetics and fluorescence spectroscopy. Colloid Polym. Sci. 1998, 276:381-387.
18. Guang Choo E.S., Yu B., Xue J. Synthesis of poly(acrylic acid) modified Pluronic® P123 copolymers for pH-stimulated release of doxorubicin. J. Colloidal. Int. Sci. 2011, 358:462-740.
19. Yang T.F., Chen M.C., Lai C.H., Liang H.W., Sung H.W. Sell-crosslinked Pluronic® L121 micelles as a drug delivery vehicle. Biomaterials 2007, 28:725-734.
20. Batrakova E.V., Kabanova A.V. Pluronic® block copolymers: evaluation of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control. Rel. 2008, 130:98-106.
21. Koo C.M., Jeon B.H., Chung I.J. The effect of poly(methyl vinyl ether-alt-maleic acid) stabilizer on the stability of solyaniline-poly(methyl vinyl ether-alt-maleic acid) dispersions. J. Colloid. Int. Sci. 2000, 227:316-321.
22. Wang Y., Chang F., Zang Y., Liu G., Gupta S., Rusckowski M., Hantowich D.J. Pretargeting with amplification using polymeric peptide nucleic acid. Bioconjug. Chem. 2001, 12(5):807-816.
23. He J., Liu G., Zhang S., Vanderheyden J.L., Liu N., Liu C., Zhangin Y., Gupta S., Rusckowski M., Hnatowich D.J. A comparison of in vitro and in vivo stability in mice of to morpholino dublexes differing in chain length. Bioconjug. Chem. 2003, 14(5):1018-1023.
24. Hernandez-Valdepena I., Domurdo M., Coudane J., Braud C., Baussard J.F., Vert M., Domurado D. Nanoaggregates of a random amphiphilic polyanion to carry water-insoluble colfazimine in neutral aqueous media. Eur. J. Pharm. Sci. 2009, 36(2-3):345-351.
25. Camp W.V., Germonpre V., Mespouille L., Dubois P., Goethals E.J., Du Prez F.E. New poly(acrylic acid) containing segmented copolymer structures by combination of ''click" chemistry and atom transfer radical polymerization. React. Funct. Polym. 2007, 67:1168-1180.
26. Yao F., Bai Y., Zhou Y., Liu C., Wang H., Yao K. Synthesis and characterization of multiblock copolymers based on l-lactic acid, citric acid, and poly(ethylene glycol). J. Polym. Sci. 2003, 41:2073-2081.
27. Chiappetta D.A., Sosnik A. Poly(ehtylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 2007, 66:303-317.
28. Wolszczak M., Miller J. Characterization of non-ionic surfactant aggregates by fluorometric techniques. J. Photochem. Photobiol. A: Chem. 2002, 147:45-54.
29. Plumb J.A., Milroy R., Kaye S.B. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 1989, 49:4435-4440.
30. Adams J.D., Rogers S.H., Schuetz P. The effect of PEO block lengths on the size and stability of complex coacervate core micelles. J. Colloid. Int. Sci. 2008, 322:448-456.
31. Balmbra R.R., Clunie J.S., Corkill J.M., Goodman J.F. Effect of temperature on the micelle size of a homogeneous non-ionic detergent. Trans. Faraday Soc. 1962, 58:1661-1667.
32. Basak R., Bandyopadhyay R. Encapsulation of hydrophobic drugs in Pluronic® f127 micelles: effects of drug hydrophobicity, solution temperature, and pH. Langmuir 2013, 29(13):4350-4356.
33. Jeong Y.I., Kim D.H., Chung C.W., Yoo J.J., Choi K.H., Kim C.H., Ha S.H., Kang D.H. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(dl-lactide-co-glycolide) copolymer. Int. J. Nanomed. 2011, 6:1415-1427.
34. Qiu L.Y., Bae Y.H. Self-assembled polyethylenimine-graft-poly(ε-caprolactone) micelles as potential dual carriers of genes and anticancer drugs. Biomaterials 2007, 28(28):4132-4142.
35. Chattopadhyay N., Zastre J., Wong H.L., Wu X.Y., Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm. Res. 2008, 25:2262-2271.
36. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloid. Surf. B: Biointerf. 2005, 45:167-173.
37. Bocca C., Caputo O., Cavalli R., Gabriel L., Miglietta A., Gasco M.R. Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int. J. Pharm. 1998, 175:185-193.
38. Gadelle F., Koros W., Schechter R. Solubilization of aromatic solutes in block copolymers. Macromolecules 1995, 28:4883-4892.
39. Nagarajan R., Barry M., Ruckenstein E. Unusual selectivity in solubilization by block copolymer micelles. Langmuir 1986, 2:210-215.
40. Xing L., Mattice W. Strong solubilization of small molecules by triblock-copolymer micelles in selective solvents. Macromolecules 1997, 30:1711-1717.
41. Tian M., Arca E., Tuzar Z., Webber S., Munk P. Light scattering study of solubilization of organic molecules by block copolymer micelles in aqueous media. J. Polym. Sci. Polym. Phys. 1995, 33:1713-1722.
42. Shuai X., Ai H., Nasongkla N., Kim S., Gao J. Micellar carriers based on block copolymers of poly(-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Rel. 2004, 98:415-426.
43. Aliabadi H., Elhasi S., Mahmud A., Gulamhusein R., Mahdipoor P., Lavasanifar A. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int. J. Pharm. 2007, 329:158-165.
44. Na K., Park K.H., Kim S.W., Bae Y.H. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J. Control. Rel. 2000, 69:225-236.
45. Sezgin Z., Ksel N.Y., Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 2006, 64:261-268.
46. Xiangyang X., Ling L., Jianping Z., Shiyue L., Jie Y., Xiaojin Y., Jinsheng R. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity. Colloid. Surf. B: Biointerf. 2007, 55(2):222-228.
47. Collett J., Tobin E. Relationships between poloxamer structure and the solubilization of some para-substituted acetanilides. J. Pharm. Pharmacol. 1979, 31:174-177.
48. Chaibundit C., Ricardo N., Costa F., Yeate S.G., Booth C. Micellization and gelation of mixed copolymers P123 and F127 in aqueous solution. Langmuir 2007, 23:9229-9236.
49. Barry B.W., El Eini D.I.D. Solubilization of hydro cortisone, dexamethasone, testosterone and progesterone by long-chain polyoxyethylene surfactants. J. Pharm. Pharmacol. 1976, 28:210-218.
50. Rangel-Yagui C.O., Pessoa Junior A., Tavares L.C. Micellar solubilization of drugs. J. Pharm. Pharmaceut. Sci. 2005, 8(2):147-163.
51. Hurter P.N., Hatton T.A. Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene oxide-propylene oxide) block copolymer micelles: effects of polymer structure. Langmuir 1992, 8(5):1291-1299.
52. Rafati H., Coombes A.G.A., Adler J., Holland J., Davis S.S. Protein-loaded poly (dl lactide-co-glycolide) microparticles for oral administration; formulation, structural and release characteristics. J. Control. Rel. 1997, 43:89-102.
53. Bodmeier R., McGinity J.W. Solvent selection in the preparation of PLA microspheres prepared by the solvent evaporation method. Int. J. Pharm. 1988, 43:179-186.
54. Teng Y., Morrison M.E., Munk P., Webber S.E., Prochazka K. Release kinetics studies of aromatic molecules into water from block polymer micelles. Macromolecules 1998, 31:3578-3587.
55. Loh W. Block copolymer micelles. Encyclopedia of Surface and Colloid Science 2002, 802-812. Marcel Dekker, Inc., New York, USA.
56. Cammas S., Suzuki K., Sone C., Sakurai Y., Kataoka K., Okano T. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J. Control. Rel. 1997, 48:157-164.
57. Chung J.E., Yokoyama M., Okano T. Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J. Control. Rel. 2000, 65:93-103.
58. Yu D.H., Lu Q., Xie J., Fang C., Chen H.Z. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel. Biomaterials 2010, 31:2278-2292.
59. Yang B., Guo C., Chen S., Ma J., Wang J., Liang X., Zheng L., Liu H. Effect of acid on the aggregation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymers. J. Phys. Chem. B 2006, 110(64):23068-23074.
60. Hu F.Q., Liu L.N., Du Y.Z., Yuan H. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials 2009, 30:6955-6963.
61. Hrubý M., Koňák Č., Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Rel. 2005, 103:137-148.
62. Gao Q., Liang Q., Yu F., Xu J., Zhao Q., Sun B. Synthesis and characterization of novel amphiphilic copolymer stearic acid-coupled F127 nanoparticles for nano-technology based drug delivery system. Colloids Surf. B: Biointerf. 2011, 88:741-748.
63. Minkoa T., Batrakovab E.V., Lib S., Lib Y., Pakunlua R.I., Alakhovc V.Y., Kabanovb A.V. Pluronic® block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J. Control. Rel. 2005, 105:269-278.
64. Rapoport N., Pitt W.G., Sun H., Nelson J.L. Drug delivery in polymeric micelles: from in vitro to in vivo. J. Control. Rel. 2003, 91:85-95.